Table I.
Clinical and histopathological characteristics in patients with thyroid cancer.
| Characteristic | Whole (n=106) | Male (n=26) | Female (n=80) | Male vs. female (P-value) |
|---|---|---|---|---|
| Age (years) | 48.67±2.26 | 0.019a | ||
| ≥50 | 37 (34.9) | 14 (53.8) | 23 (28.8) | |
| <50 | 69 (65.1) | 12 (46.2) | 57 (71.2) | |
| Tumor size (mean ± SEM) | 9.5±0.9 | 10.2±0.6 | 9.1±1.3 | 0.465 |
| Degree of differentiation | 4/34/64 | 1/8/15 | 3/26/49 | 0.997 |
| (poor/intermediate/good) | (3.9/33.3/62.7%) | (4.2/33.3/62.5%) | (3.8/33.3/62.8%) | |
| Capsule invasion | 62 (58.5%) | 13 (0.5%) | 49 (61.5%) | 0.315 |
| Vascular invasion | 26 (24.5%) | 3 (2.9%) | 21 (26.9%) | 0.076 |
| Stages | 0.727 | |||
| I+II | 89 (83.9%) | 22 (84.6%) | 67 (83.8%) | |
| III+IV | 17 (16.1 %) | 4 (15.4%) | 13 (16.2%) | |
| Pathological types | 0.141 | |||
| Papillary cancer | 68 (64.1%) | 17 (65.4%) | 51 (63.8%) | |
| Follicular cancer | 23 (21.7%) | 6 (23%) | 17 (21.2%) | |
| Medullary cancer | 12 (11.3%) | 3 (11.5%) | 9 (11.3%) | |
| Undifferentiated Cancer | 3 (2.8%) | 2(7.6%) | 1 (1.3%) |
a
P<0.05, comparison between the ages of male subgroup and female subgroup. SEM, standard error of the mean.